Markets:

Overview

News

Currencies

International

Treasuries

bioAffinity Technologies, Inc. - Common Stock (NQ:BIAF)

2.250 +1.180 (+110.28%)

Streaming Delayed Price Updated: 2:49 PM EDT, Mar 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about bioAffinity Technologies, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

bioAffinity Technologies to Ring Nasdaq Closing Bell Today

April 05, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial Results

March 31, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Announces Publication of Peer-Reviewed Paper on Proprietary Beads Used in CyPath® Lung for Noninvasive Detection of Early-Stage Lung Cancer

March 28, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

Why Is BioAffinity (BIAF) Stock Up 40% Today? ↗

September 28, 2022

BioAffinity received roughly $7.7 million in warrant exercises, bringing a cash infusion to the otherwise challenged BIAF stock.

Via InvestorPlace

bioAffinity Technologies to Report Fourth Quarter 2022 Financial Results on March 31, 2023

March 24, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 17, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 14, 2023

Via Benzinga

bioAffinity Technologies Appoints Julie Anne Overton Director of Corporate Communications

February 13, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

Dow Rises 80 Points; Altamira Therapeutics Shares Plunge ↗

January 24, 2023

U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 80 points on Tuesday. The Dow traded up 0.24% to 33,710.06 while the NASDAQ fell 0.21% to 11,340.24. The S&P 500...

Via Benzinga

Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 24, 2023

Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares surged 59.7% to $5.03 after the company announced the outcome of its first interim analysis in a Phase II trial of BX1000 for neuromuscular blockade in...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 24, 2023

Via Benzinga

Dow Edges Higher; Crude Oil Down 1% ↗

January 24, 2023

U.S. stocks traded mostly flat midway through trading, with the Dow Jones trading slightly higher on Tuesday. The Dow traded up 0.03% to 33,638.42 while the NASDAQ fell 0.07% to 11,356.65. The S&P 500...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 24, 2023

Via Benzinga

bioAffinity Technologies Announces Publication of Results of Clinical Trial in Peer-Reviewed Journal Respiratory Research

January 24, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Announces Notice to Award U.S. Patent Protecting Novel Compounds for Specific Delivery of Cancer Treatments

January 04, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 28, 2022

Via Benzinga

bioAffinity Technologies Expands Diagnostic Division with Promotions and New Hires to Strengthen Clinical Bench

December 15, 2022

From bioAffinity Technologies, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 09, 2022

Via Benzinga

bioAffinity Technologies Presents Proprietary Cancer Therapeutic Research at Joint ASCB-EMBO Meeting

December 01, 2022

From bioAffinity Technologies, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 30, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 21, 2022

Via Benzinga

bioAffinity Technologies Reports Third Quarter 2022 Financial Results and Provides Business Update

November 14, 2022

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Announces Sheila Habib, MD and David Hill, MD Join the Company’s Scientific and Medical Advisory Board

November 10, 2022

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies to Report Third Quarter 2022 Financial Results

November 08, 2022

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Announces Award of Therapeutic Patents in China, Mexico and Australia

October 25, 2022

From bioAffinity Technologies, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 21, 2022

Gainers Statera BioPharma (NASDAQ:STAB) shares increased by 33.1% to $0.2 during Friday's pre-market session. The company's market cap stands at $10.4 million.

Via Benzinga

bioAffinity Technologies Presents Results from Flow Cytometry Analysis of the Lung at CHEST Conference

October 12, 2022

From bioAffinity Technologies, Inc.

Via Business Wire

Why Amylyx Pharmaceuticals Is Trading Higher By Over 8%; Here Are 22 Stocks Moving Premarket ↗

September 30, 2022

Gainers SAI.TECH Global Corporation (NASDAQ: SAI) rose 42% to $3.21 in pre-market trading after dipping 26% on Thursday. SAI.TECH recently announced the launch of new liquid cooling Bitcoin mining...

Via Benzinga

7 Penny Sleeper Stocks to Buy Before Wall Street Wakes Up ↗

September 29, 2022

While these market ideas are risky, they offer enough relevance to be intriguing.

Via InvestorPlace

Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday ↗

September 29, 2022

Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.